Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2026-05-04 16:37:33 ET · period of report 2026-05-01 · accession 0001193125-26-204136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 16:37 | 2026-05-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | F - Tax | $14.07 | -97 | 27.5K | -0.4% | -$1,365 |
| D | 2026-05-04 16:37 | 2026-05-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | +250 | 27.6K | +0.9% | $0 |
| D | 2026-05-04 16:37 | 2026-05-01 | CLB | Tattoli Mark Damian | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -250 | 1,200 | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | F | D | 97 | $14.07 | 27,513.62 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-01 | M | A | 250 | $0.00 | 27,610.62 | D | — | — | |
| 3 | Derivative | Restricted Shares | 2026-05-01 | M | D | 250 | $0.00 | 1,200 | D | $0.00 · — to — | 250 Common Stock | (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. (F1) The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. (F2) Multiple restricted share grants are included in this total. |